These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3992882)

  • 1. Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose.
    Heath A; Svensson C; Mårtensson E
    Vet Hum Toxicol; 1985 Apr; 27(2):100-5. PubMed ID: 3992882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
    Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
    Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of thioridazine on electrical and ischemic ventricular fibrillation in the dog heart in situ.
    Davis JC; Bigger JT
    J Pharmacol Exp Ther; 1981 Jan; 216(1):39-44. PubMed ID: 7452506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiotoxicity of thioridazine and two stereoisomeric forms of thioridazine 5-sulfoxide in the isolated perfused rat heart.
    Hale PW; Poklis A
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):44-55. PubMed ID: 3764935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioridazine-5-sulfoxide cardiotoxicity in the isolated, perfused rat heart.
    Hale PW; Poklis A
    Toxicol Lett; 1984 Apr; 21(1):1-8. PubMed ID: 6719481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
    Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
    Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
    Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biotransformation of thioridazine to thioridazine 5-sulfoxide stereoisomers in phenobarbital induced rats.
    Hale PW; Poklis A
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):283-9. PubMed ID: 3582423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute overdosage with thioridazine: a review of the available clinical exposure.
    Le Blaye I; Donatini B; Hall M; Krupp P
    Vet Hum Toxicol; 1993 Apr; 35(2):147-50. PubMed ID: 8470359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
    Svensson C; Nyberg G; Axelsson R; Mårtensson E
    Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation and configurational changes of thioridazine 2-sulfoxide.
    de Gaitani CM; Martinez AS; Bonato PS
    J Pharm Biomed Anal; 2004 Nov; 36(3):601-7. PubMed ID: 15522536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupivacaine cardiovascular toxicity: comparison of treatment with bretylium and lidocaine.
    Kasten GW; Martin ST
    Anesth Analg; 1985 Sep; 64(9):911-6. PubMed ID: 4025854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioridazine 5-sulfoxide diastereoisomers in serum and urine from rats and man after chronic thioridazine administration.
    Hale PW; Poklis A
    J Anal Toxicol; 1985; 9(5):197-201. PubMed ID: 4057956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic changes following intravenous administration of thioridazine to macaque monkeys.
    Moore RH; Rainey JM
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):41-3. PubMed ID: 7076640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
    Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
    J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drugs and long QT syndromes: case reports.
    Flugelman MY; Tal A; Pollack S; Hefez A; Weisstub EB; Gotsman MS; Lewis BS
    J Clin Psychiatry; 1985 Jul; 46(7):290-1. PubMed ID: 4008455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case report. Torsades de pointes caused by overdose of thioridazine].
    Näsh O; Rydenhag A
    Lakartidningen; 1993 Oct; 90(42):3677-8, 3681. PubMed ID: 8231516
    [No Abstract]   [Full Text] [Related]  

  • 20. Endophytic fungi as models for the stereoselective biotransformation of thioridazine.
    Borges KB; Borges Wde S; Pupo MT; Bonato PS
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):669-74. PubMed ID: 17876580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.